BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 34403083)

  • 1. Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management.
    Zhou C; Li X; Wang C; Zhang J
    Clin Rev Allergy Immunol; 2021 Dec; 61(3):403-423. PubMed ID: 34403083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options.
    Sterkens A; Lambert J; Bervoets A
    Clin Exp Med; 2021 May; 21(2):215-230. PubMed ID: 33386567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood Alopecia Areata: An Overview of Treatment and Recent Patents.
    Hon KL; Luk DCK; Leung AKC; Ng C; Loo SKF
    Recent Pat Inflamm Allergy Drug Discov; 2020; 14(2):117-132. PubMed ID: 32723274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines.
    Fukuyama M; Ito T; Ohyama M
    J Dermatol; 2022 Jan; 49(1):19-36. PubMed ID: 34709679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The autoimmune basis of alopecia areata: a comprehensive review.
    Islam N; Leung PS; Huntley AC; Gershwin ME
    Autoimmun Rev; 2015 Feb; 14(2):81-9. PubMed ID: 25315746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.
    Gilhar A; Schrum AG; Etzioni A; Waldmann H; Paus R
    Autoimmun Rev; 2016 Jul; 15(7):726-35. PubMed ID: 26971464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of alopecia areata: An Australian expert consensus statement.
    Cranwell WC; Lai VW; Photiou L; Meah N; Wall D; Rathnayake D; Joseph S; Chitreddy V; Gunatheesan S; Sindhu K; Sharma P; Green J; Eisman S; Yip L; Jones L; Sinclair R
    Australas J Dermatol; 2019 May; 60(2):163-170. PubMed ID: 30411329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of T-cell activity in alopecia areata: recent developments and new directions.
    Passeron T; King B; Seneschal J; Steinhoff M; Jabbari A; Ohyama M; Tobin DJ; Randhawa S; Winkler A; Telliez JB; Martin D; Lejeune A
    Front Immunol; 2023; 14():1243556. PubMed ID: 38022501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors.
    Paggioli I; Moss J
    J Autoimmun; 2022 Dec; 133():102926. PubMed ID: 36335798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric Alopecia Areata.
    Afford R; Leung AKC; Lam JM
    Curr Pediatr Rev; 2021; 17(1):45-54. PubMed ID: 32351186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ritlecitinib: an investigational drug for the treatment of moderate to severe alopecia areata.
    Eisman S; Sinclair R
    Expert Opin Investig Drugs; 2021 Dec; 30(12):1169-1174. PubMed ID: 34826225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Alopecia Areata: Current Practices Versus New Directions.
    Gupta AK; Carviel J; Abramovits W
    Am J Clin Dermatol; 2017 Feb; 18(1):67-75. PubMed ID: 27770310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel investigational drugs for alopecia areata and future perspectives.
    Chim I; Ghiya R; Sinclair RD; Eisman S
    Expert Opin Investig Drugs; 2024 May; 33(5):441-449. PubMed ID: 38682280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alopecia areata.
    Pratt CH; King LE; Messenger AG; Christiano AM; Sundberg JP
    Nat Rev Dis Primers; 2017 Mar; 3():17011. PubMed ID: 28300084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata.
    Wasserman D; Guzman-Sanchez DA; Scott K; McMichael A
    Int J Dermatol; 2007 Feb; 46(2):121-31. PubMed ID: 17269961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis.
    Strazzulla LC; Wang EHC; Avila L; Lo Sicco K; Brinster N; Christiano AM; Shapiro J
    J Am Acad Dermatol; 2018 Jan; 78(1):1-12. PubMed ID: 29241771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.
    Lensing M; Jabbari A
    Front Immunol; 2022; 13():955035. PubMed ID: 36110853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Janus kinase inhibitors for alopecia areata.
    King BA; Craiglow BG
    J Am Acad Dermatol; 2023 Aug; 89(2S):S29-S32. PubMed ID: 37591562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.